Title : Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer's disease: Quinolotacrine hybrids.

Pub. Date : 2022 Feb

PMID : 34491490






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Of these compounds, cyclohexa-quinolotacrine hybrids displayed a little better anti-AChE activity than cyclopenta-quinolotacrine hybrids. cyclohexa acetylcholinesterase Rattus norvegicus
2 Of these compounds, cyclohexa-quinolotacrine hybrids displayed a little better anti-AChE activity than cyclopenta-quinolotacrine hybrids. quinolotacrine acetylcholinesterase Rattus norvegicus
3 Of these compounds, cyclohexa-quinolotacrine hybrids displayed a little better anti-AChE activity than cyclopenta-quinolotacrine hybrids. cyclopenta-quinolotacrine acetylcholinesterase Rattus norvegicus
4 As a result, these quinolotacrine hybrids can be very encouraging AChE inhibitors to treat Alzheimer"s disease. quinolotacrine acetylcholinesterase Rattus norvegicus
5 A novel series of quinolotacrine hybrids were designed, synthesized, and evaluated against AChE and BChE enzymes as potential agents for the treatment of AD. quinolotacrine acetylcholinesterase Rattus norvegicus